↓ Skip to main content

Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study

Overview of attention for article published in Frontiers in Neurology, March 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study
Published in
Frontiers in Neurology, March 2023
DOI 10.3389/fneur.2023.1154420
Pubmed ID
Authors

Lucas Hendrik Overeem, Kristin Sophie Lange, Mira Pauline Fitzek, Anke Siebert, Maureen Steinicke, Paul Triller, Ja Bin Hong, Uwe Reuter, Bianca Raffaelli

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 13%
Student > Ph. D. Student 1 13%
Researcher 1 13%
Other 1 13%
Student > Master 1 13%
Other 0 0%
Unknown 3 38%
Readers by discipline Count As %
Neuroscience 2 25%
Pharmacology, Toxicology and Pharmaceutical Science 1 13%
Unspecified 1 13%
Unknown 4 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 March 2023.
All research outputs
#13,785,577
of 23,485,204 outputs
Outputs from Frontiers in Neurology
#5,347
of 12,407 outputs
Outputs of similar age
#97,280
of 250,708 outputs
Outputs of similar age from Frontiers in Neurology
#79
of 456 outputs
Altmetric has tracked 23,485,204 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,407 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,708 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 456 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.